New hope for stomach cancer: Real-World study explores better Second-Line treatments
NCT ID NCT07389876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at different drug combinations for people with advanced stomach or gastroesophageal junction cancer that has not responded to first-line treatment. Researchers will observe 250 participants receiving albumin-bound paclitaxel-based regimens, including immune checkpoint inhibitors or anti-angiogenic drugs. The goal is to see how well these treatments shrink tumors and improve survival in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Albumin-bound paclitaxel (a chemotherapy drug) combined with other drugs like immune checkpoint inhibitors or anti-angiogenic drugs
- What this could lead to
- If successful, this could help identify more effective second-line treatment options for advanced gastric cancer, potentially improving survival and quality of life.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. It is also early-stage research, and benefits may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wanjing Feng
RECRUITINGShanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can surgery for stomach or esophageal cancer cloud the mind?